In vivo production of novel vitamin D2 hydroxy-derivatives by human placentas, epidermal keratinocytes, Caco-2 colon cells and the adrenal gland

Molecular and Cellular Endocrinology

Volumn 383, Issue 1-2, 2014, Pages 181-192

  Slominski, Andrzej T ^a   Kim, Tae Kang ^a   Shehabi, Haleem Z ^b   Tang, Edith K Y ^c   Benson, Heather A E ^b   Semak, Igor ^d   Lin, Zongtao ^a   Yates, Charles R ^a   Wang, Jin ^a   Li, Wei ^a   Tuckey, Robert C ^c  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b CURTIN UNIVERSITY   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d BELARUSIAN STATE UNIVERSITY   (Belarus)

Author keywords

20 Hydroxyvitmin D2; Adrenals; CYP11A1; Keratinocytes; Placenta; Vitamin D

Indexed keywords

CHOLESTEROL MONOOXYGENASE (SIDE CHAIN CLEAVING); CYTOCHROME; CYTOCHROME P450 CYP27B1; ERGOCALCIFEROL; UNCLASSIFIED DRUG;

ADRENAL GLAND; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVITY; ENZYME METABOLISM; ENZYME PURIFICATION; FLOW RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYDROXYLATION; IN VIVO STUDY; ISOMERIZATION; KERATINOCYTE; MELANOCYTE; MITOCHONDRION; MOLECULAR MODEL; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TISSUE SPECIFICITY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; VITAMIN METABOLISM;

20-HYDROXYVITMIN D2; ADRENALS; CYP11A1; KERATINOCYTES; PLACENTA; VITAMIN D;

25-HYDROXYVITAMIN D3 1-ALPHA-HYDROXYLASE; ADRENAL GLANDS; ANIMALS; CACO-2 CELLS; CHOLESTEROL SIDE-CHAIN CLEAVAGE ENZYME; EPIDERMIS; ERGOCALCIFEROLS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; HYDROXYCHOLESTEROLS; HYDROXYLATION; KERATINOCYTES; KETOCONAZOLE; MITOCHONDRIA; ORGAN SPECIFICITY; PLACENTA; PREGNANCY; RATS; RATS, WISTAR; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; TISSUE CULTURE TECHNIQUES;

EID: 84892552542     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2013.12.012     Document Type: Article

References (50)

1. Bikle D.D. Vitamin D receptor, UVR, and skin cancer: a potential protective mechanism. J. Invest. Dermatol. 2008, 128:2357-2361.
2. Bikle D.D. The vitamin D receptor: a tumor suppressor in skin. Discov. Med. 2011, 11:7-17.
3. Bikle D.D. Vitamin D: an ancient hormone. Exp. Dermatol. 2011, 20:7-13.
4. Bikle D.D., Nemanic M.K., Gee E., Elias P. 1,25-Dihydroxyvitamin D3 production by human keratinocytes. Kinetics and regulation. J. Clin. Invest. 1986, 78:557-566.
5. Chen J., Li C.M., Wang J., Ahn S., Wang Z., Lu Y., Dalton J.T., Miller D.D., Li W. Synthesis and antiproliferative activity of novel 2-aryl-4-benzoyl-imidazole derivatives targeting tubulin polymerization. Bioorg. Med. Chem. 2011, 19:4782-4795.
6. Fleet J.C., Wang L., Vitek O., Craig B.A., Edenberg H.J. Gene expression profiling of Caco-2 BBe cells suggests a role for specific signaling pathways during intestinal differentiation. Physiol. Genomics. 2003, 13:57-68.
7. Guryev O., Carvalho R.A., Usanov S., Gilep A., Estabrook R.W. A pathway for the metabolism of vitamin D3: unique hydroxylated metabolites formed during catalysis with cytochrome P450scc (CYP11A1). Proc. Natl. Acad. Sci. USA 2003, 100:14754-14759.
8. Holick M.F. Vitamin D: a millenium perspective. J. Cell. Biochem. 2003, 88:296-307.
9. Holick M.F. Vitamin D deficiency. N. Eng. J. Med. 2007, 357:266-281.
10. Holick M.F., Clark M.B. The photobiogenesis and metabolism of vitamin D. Fed. Proc. 1978, 37:2567-2574.
11. Holick M.F., Holick S.A., Tavela T., Gallagher B., Schnoes H.K., DeLuca H.F. Synthesis of (6-3H)-1alpha-hydroxyvitamin D3 and its metabolism in vivo to (3H)-1alpha,25-dihydroxyvitamin D3. Science 1975, 190:576-578.
12. Holick M.F., Tian X.Q., Allen M. Evolutionary importance for the membrane enhancement of the production of vitamin D3 in the skin of poikilothermic animals. Proc. Natl. Acad. Sci. USA 1995, 92:3124-3126.
13. Hong S.P., Kim M.J., Jung M.Y., Jeon H., Goo J., Ahn S.K., Lee S.H., Elias P.M., Choi E.H. Biopositive effects of low-dose UVB on epidermis: coordinate upregulation of antimicrobial peptides and permeability barrier reinforcement. J. Invest. Dermatol. 2008, 128:2880-2887.
14. Hume R., Kelly R.W., Taylor P.L., Boyd G.S. The catalytic cycle of cytochrome P-450scc and intermediates in the conversion of cholesterol to pregnenolone. Eur. J. Biochem. 1984, 140:583-591.
15. Janjetovic Z., Zmijewski M.A., Tuckey R.C., DeLeon D.A., Nguyen M.N., Pfeffer L.M., Slominski A.T. 20-Hydroxycholecalciferol, product of vitamin D3 hydroxylation by P450scc, decreases NF-kappaB activity by increasing IkappaB alpha levels in human keratinocytes. PLoS ONE 2009, 4:e5988.
16. Janjetovic Z., Tuckey R.C., Nguyen M.N., Thorpe E.M., Slominski A.T. 20,23-Dihydroxyvitamin D3, novel P450scc product, stimulates differentiation and inhibits proliferation and NF-kappaB activity in human keratinocytes. J. Cell. Physiol. 2010, 223:36-48.
17. Janjetovic Z., Brozyna A.A., Tuckey R.C., Kim T.K., Nguyen M.N., Jozwicki W., Pfeffer S.R., Pfeffer L.M., Slominski A.T. High basal NF-kappaB activity in nonpigmented melanoma cells is associated with an enhanced sensitivity to vitamin D3 derivatives. Br. J. Cancer 2011, 105:1874-1884.
18. Kim T.-K., Wang J., Janjetovic Z., Chen J., Tuckey R.C., Nguyen M.N., Tang E.K.Y., Miller D., Li W., Slominski A.T. Correlation between secosteroid induced vitamin D receptor activity in melanoma cells and computer-modeled receptor binding strength. Mol. Cell. Endocrinol. 2012, 361:143-152.
19. Lehmann B. HaCaT cell line as a model system for vitamin D3 metabolism in human skin. J. Invest. Dermatol. 1997, 108:78-82.
20. Lehmann B., Genehr T., Knuschke P., Pietzsch J., Meurer M. UVB-induced conversion of 7-dehydrocholesterol to 1alpha,25-dihydroxyvitamin D3 in an in vitro human skin equivalent model. J. Invest. Dermatol. 2001, 117:1179-1185.
21. Lehmann B., Sauter W., Knuschke P., Dressler S., Meurer M. Demonstration of UVB-induced synthesis of 1 alpha,25-dihydroxyvitamin D3 (calcitriol) in human skin by microdialysis. Arch. Dermatol. Res. 2003, 295:24-28.
22. Miller W.L., Auchus R.J. The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders. Endocr. Rev. 2011, 32:81-151.
23. Nguyen M.N., Slominski A., Li W., Ng Y.R., Tuckey R.C. Metabolism of vitamin d2 to 17,20,24-trihydroxyvitamin d2 by cytochrome p450scc (CYP11A1). Drug Metab. Dispos.: Biol. Fate Chem. 2009, 37:761-767.
24. Olsen L., Rydberg P., Rod T.H., Ryde U. Prediction of activation energies for hydrogen abstraction by cytochrome p450. J. Med. Chem. 2006, 49:6489-6499.
25. Plum L.A., DeLuca H.F. Vitamin D, disease and therapeutic opportunities. Nat. Rev. Drug Discov. 2010, 9:941-955.
26. Sidler D., Renzulli P., Schnoz C., Berger B., Schneider-Jakob S., Fluck C., Inderbitzin D., Corazza N., Candinas D., Brunner T. Colon cancer cells produce immunoregulatory glucocorticoids. Oncogene 2011, 30:2411-2419.
27. Slominski A., Zjawiony J., Wortsman J., Semak I., Stewart J., Pisarchik A., Sweatman T., Marcos J., Dunbar C.C., Tuckey R.C. A novel pathway for sequential transformation of 7-dehydrocholesterol and expression of the P450scc system in mammalian skin. Eur. J. Biochem. 2004, 271:4178-4188.
28. Slominski A., Semak I., Zjawiony J., Wortsman J., Li W., Szczesniewski A., Tuckey R.C. The cytochrome P450scc system opens an alternate pathway of vitamin D3 metabolism. FEBS J. 2005, 272:4080-4090.
29. Slominski A., Semak I., Wortsman J., Zjawiony J., Li W., Zbytek B., Tuckey R.C. An alternative pathway of vitamin D metabolism. Cytochrome P450scc (CYP11A1)-mediated conversion to 20-hydroxyvitamin D2 and 17,20-dihydroxyvitamin D2. FEBS J. 2006, 273:2891-2901.
30. Slominski A.T., Janjetovic Z., Fuller B.E., Zmijewski M.A., Tuckey R.C., Nguyen M.N., Sweatman T., Li W., Zjawiony J., Miller D., Chen T.C., Lozanski G., Holick M.F. Products of vitamin D3 or 7-dehydrocholesterol metabolism by cytochrome P450scc show anti-leukemia effects, having low or absent calcemic activity. PLoS ONE 2010, 5:e9907.
31. Slominski A.T., Kim T.K., Janjetovic Z., Tuckey R.C., Bieniek R., Yue J., Li W., Chen J., Nguyen M.N., Tang E.K., Miller D., Chen T.C., Holick M. 20-Hydroxyvitamin D2 is a noncalcemic analog of vitamin D with potent antiproliferative and prodifferentiation activities in normal and malignant cells. Am. J. Physiol. Cell Physiol. 2011, 300. C526-C541.
32. Slominski A.T., Janjetovic Z., Kim T.K., Wright A.C., Grese L.N., Riney S.J., Nguyen M.N., Tuckey R.C. Novel vitamin D hydroxyderivatives inhibit melanoma growth and show differential effects on normal melanocytes. Anticancer Res. 2012, 32:3733-3742.
33. Slominski A.T., Kim T.-K., Shehabi H.Z., Semak I., Tang E.K.Y., Nguyen M.N., Benson H.A.E., Korik E., Janjetovic Z., Chen J., Yates C.R., Postlethwaite A., Li W., Tuckey R.C. In vivo evidence for a novel pathway of vitamin D3 metabolism initiated by P450scc and modified by CYP27B1. FASEB J. 2012, 26:3901-3915.
34. Slominski A.T., Kim T.K., Chen J., Nguyen M.N., Li W., Yates C.R., Sweatman T., Janjetovic Z., Tuckey R.C. Cytochrome P450scc-dependent metabolism of 7-dehydrocholesterol in placenta and epidermal keratinocytes. Int. J. Biochem. Cell Biol. 2012, 44:2003-2018.
35. Slominski A., Janjetovic Z., Tuckey R.C., Nguyen M.N., Bhattacharya K.G., Wang J., Li W., Jiao Y., Gu W., Brown M., Postlethwaite A.E. 20S-Hydroxyvitamin D3, noncalcemic product of CYP11A1 action on vitamin D3, exhibits potent antifibrogenic activity in vivo. J. Clin. Endocrinol. Metab. 2013, 98:E298-E303.
36. Slominski A., Zbytek B., Nikolakis G., Manna P.R., Skobowiat C., Zmijewski M., Li W., Janjetovic Z., Postlethwaite A., Zouboulis C.C., Tuckey R.C. Steroidogenesis in the skin: implications for local immune functions. J. Steroid. Biochem. Mol. Biol. 2013, 137:107-123.
37. Slominski A.T., Kim T.K., Li W., Yi A.K., Postlethwaite A., Tuckey R.C. The role of CYP11A1 in the production of vitamin D metabolites and their role in the regulation of epidermal functions. J. Steroid. Biochem. Mol. Biol. 2013, 10.1016/j.jsbmb.2013.10.012.
38. Strushkevich N., MacKenzie F., Cherkesova T., Grabovec I., Usanov S., Park H.W. Structural basis for pregnenolone biosynthesis by the mitochondrial monooxygenase system. Proc. Natl. Acad. Sci. USA 2011, 108:10139-10143.
39. Tang E.K., Li W., Janjetovic Z., Nguyen M.N., Wang Z., Slominski A., Tuckey R.C. Purified mouse CYP27B1 can hydroxylate 20,23-dihydroxyvitamin D3, producing 1alpha,20,23-trihydroxyvitamin D3, which has altered biological activity. Drug Metab. Dispos. 2010, 38:1553-1559.
40. Tang E.K., Chen J., Janjetovic Z., Tieu E.W., Slominski A.T., Li W., Tuckey R.C. Hydroxylation of CYP11A1-derived products of vitamin D3 metabolism by human and mouse CYP27B1. Drug Metab. Dispos.: Biol. Fate Chem. 2013, 41:1112-1124.
41. Taves M.D., Gomez-Sanchez C.E., Soma K.K. Extra-adrenal glucocorticoids and mineralocorticoids: evidence for local synthesis, regulation, and function. Am. J. Physiol. Endocrinol. Metab. 2011, 301:E11-E24.
42. Tuckey R.C. Progesterone synthesis by the human placenta. Placenta 2005, 26:273-281.
43. Tuckey R.C., Cameron K.J. Catalytic properties of cytochrome P-450scc purified from the human placenta: comparison to bovine cytochrome P-450scc. Biochim. Biophys. Acta. 1993, 1163:185-194.
44. Tuckey R.C., Li W., Zjawiony J.K., Zmijewski M.A., Nguyen M.N., Sweatman T., Miller D., Slominski A. Pathways and products for the metabolism of vitamin D3 by cytochrome P450scc. FEBS J. 2008, 275:2585-2596.
45. Tuckey R.C., Nguyen M.N., Slominski A. Kinetics of vitamin D3 metabolism by cytochrome P450scc (CYP11A1) in phospholipid vesicles and cyclodextrin. Int. J. Biochem. Cell Biol. 2008, 40:2619-2626.
46. Tuckey R.C., Li W., Shehabi H.Z., Janjetovic Z., Nguyen M.N., Kim T.K., Chen J., Howell D.E., Benson H.A., Sweatman T., Baldisseri D.M., Slominski A. Production of 22-hydroxy metabolites of vitamin d3 by cytochrome p450scc (CYP11A1) and analysis of their biological activities on skin cells. Drug Metab. Dispos. 2011, 39:1577-1588.
47. Woods S.T., Sadleir J., Downs T., Triantopoulos T., Headlam M.J., Tuckey R.C. Expression of catalytically active human cytochrome p450scc in Escherichia coli and mutagenesis of isoleucine-462. Arch. Biochem. Biophys. 1998, 353:109-115.
48. Zbytek B., Janjetovic Z., Tuckey R.C., Zmijewski M.A., Sweatman T.W., Jones E., Nguyen M.N., Slominski A.T. 20-Hydroxyvitamin D3, a product of vitamin D3 hydroxylation by cytochrome P450scc, stimulates keratinocyte differentiation. J. Invest. Dermatol. 2008, 128:2271-2280.
49. Zehnder D., Evans K.N., Kilby M.D., Bulmer J.N., Innes B.A., Stewart P.M., Hewison M. The ontogeny of 25-hydroxyvitamin D(3) 1alpha-hydroxylase expression in human placenta and decidua. Am. J. Pathol. 2002, 161:105-114.
50. Zhu J., DeLuca H.F. Vitamin D 25-hydroxylase - four decades of searching, are we there yetα. Arch. Biochem. Biophys. 2012, 523:30-36.